Benjamin L. Ebert
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Cancer Research top 0.01%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Hematology 164
- Acute Myeloid Leukemia Research 126
- Multiple Myeloma Research and Treatments 17
- Genetics 91
- Myeloproliferative Neoplasms: Diagnosis and Treatment 63
- Co-authors
- Todd R. Golub (21 shared papers)Pablo Tamayo (6 shared papers)Jill P. Mesirov (2 shared papers)Michael A. Gillette (2 shared papers)Aravind N. Subramanian (2 shared papers)Sayan Mukherjee (1 shared paper)Eric S. Lander (1 shared paper)Scott L. Pomeroy (1 shared paper)
- Journals
- Blood (87 papers)Leukemia (11 papers)Journal of Clinical Oncology (10 papers)Blood Advances (9 papers)Cancer Cell (7 papers)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Benjamin L. Ebert
297 papers receiving 77.1k citations
Benjamin L. Ebert's Hit Papers
Peers
Comparison fields: 5 of 200
- Hematology 14.6k
- Cancer Research 17.1k
- Genetics 8.7k
- Molecular Biology 42.8k
- Immunology 8.4k
Countries citing papers authored by Benjamin L. Ebert
This map shows the geographic impact of Benjamin L. Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin L. Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin L. Ebert more than expected).
Fields of papers citing papers by Benjamin L. Ebert
This network shows the impact of papers produced by Benjamin L. Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin L. Ebert. The network helps show where Benjamin L. Ebert may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin L. Ebert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 308 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles Hit paper breakdown → | 2005 | 35834 |
| 2 | MicroRNA expression profiles classify human cancers Hit paper breakdown → | 2005 | 8188 |
| 3 | Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells Hit paper breakdown → | 2013 | 3835 |
| 4 | Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes Hit paper breakdown → | 2015 | 1399 |
| 5 | Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells Hit paper breakdown → | 2013 | 1393 |
| 6 | Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation Hit paper breakdown → | 2014 | 1219 |
| 7 | Clinical Effect of Point Mutations in Myelodysplastic Syndromes Hit paper breakdown → | 2011 | 1214 |
| 8 | MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia Hit paper breakdown → | 2006 | 1135 |
| 9 | Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia Hit paper breakdown → | 2010 | 875 |
| 10 | Stem cell gene expression programs influence clinical outcome in human leukemia Hit paper breakdown → | 2011 | 794 |
| 11 | Clonal hematopoiesis in human aging and disease Hit paper breakdown → | 2019 | 720 |
| 12 | Perivascular Gli1+ Progenitors Are Key Contributors to Injury-Induced Organ Fibrosis Hit paper breakdown → | 2014 | 720 |
| 13 | Identification of RPS14 as a 5q- syndrome gene by RNA interference screen Hit paper breakdown → | 2008 | 697 |
| 14 | Acute myeloid leukemia ontogeny is defined by distinct somatic mutations Hit paper breakdown → | 2014 | 681 |
| 15 | Ribosomopathies: human disorders of ribosome dysfunction Hit paper breakdown → | 2010 | 619 |
| 16 | ( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversible Hit paper breakdown → | 2013 | 553 |
| 17 | Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation Hit paper breakdown → | 2017 | 531 |
| 18 | 1995 | 501 | |
| 19 | 1995 | 499 | |
| 20 | 1994 | 467 |
About Benjamin L. Ebert
Benjamin L. Ebert is a scholar working on Hematology, Genetics, Molecular Biology, Cancer Research and Immunology, having authored 308 papers that have together received 78.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (126 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (63 papers), Protein Degradation and Inhibitors (35 papers), RNA modifications and cancer (33 papers), Epigenetics and DNA Methylation (26 papers), Ubiquitin and proteasome pathways (25 papers), Cancer Genomics and Diagnostics (22 papers) and Multiple Myeloma Research and Treatments (17 papers). The work is most often cited by research in Hematology (14.6k citations), Cancer Research (17.1k citations), Genetics (8.7k citations), Molecular Biology (42.8k citations) and Immunology (8.4k citations). Benjamin L. Ebert has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Todd R. Golub, Pablo Tamayo, Jill P. Mesirov, Michael A. Gillette, Aravind N. Subramanian, Sayan Mukherjee, Eric S. Lander, Scott L. Pomeroy, Vamsi Krishna Mootha and Amanda G. Paulovich. Their work appears in journals such as Blood, Leukemia, Journal of Clinical Oncology, Blood Advances and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.